Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, Optical Coherence | 14 | 2024 | 227 | 2.770 |
Why?
|
| Intracranial Aneurysm | 12 | 2024 | 374 | 2.740 |
Why?
|
| Stents | 8 | 2024 | 493 | 1.620 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 2238 | 1.380 |
Why?
|
| Self Expandable Metallic Stents | 5 | 2020 | 33 | 1.100 |
Why?
|
| Rabbits | 10 | 2024 | 333 | 1.060 |
Why?
|
| Thrombosis | 5 | 2020 | 198 | 1.040 |
Why?
|
| Phosphorylcholine | 2 | 2024 | 44 | 0.960 |
Why?
|
| Endovascular Procedures | 8 | 2024 | 607 | 0.880 |
Why?
|
| Embolization, Therapeutic | 6 | 2020 | 328 | 0.830 |
Why?
|
| Heparin | 1 | 2024 | 116 | 0.800 |
Why?
|
| Peroxidase | 1 | 2023 | 70 | 0.790 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 24 | 0.660 |
Why?
|
| Animals | 29 | 2024 | 20962 | 0.650 |
Why?
|
| Aneurysm | 1 | 2020 | 58 | 0.630 |
Why?
|
| Aspirin | 2 | 2020 | 172 | 0.630 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 176 | 0.610 |
Why?
|
| Dogs | 9 | 2024 | 332 | 0.590 |
Why?
|
| Stroke | 7 | 2023 | 1196 | 0.560 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 233 | 0.560 |
Why?
|
| Brain Ischemia | 4 | 2022 | 421 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 2218 | 0.460 |
Why?
|
| Thrombectomy | 7 | 2023 | 242 | 0.430 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2019 | 87 | 0.420 |
Why?
|
| Catheters | 5 | 2020 | 78 | 0.400 |
Why?
|
| Basilar Artery | 2 | 2024 | 32 | 0.370 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2023 | 70 | 0.370 |
Why?
|
| Cerebral Angiography | 4 | 2023 | 295 | 0.370 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2024 | 138 | 0.370 |
Why?
|
| Cerebral Arteries | 2 | 2024 | 40 | 0.370 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 145 | 0.360 |
Why?
|
| Models, Anatomic | 3 | 2023 | 63 | 0.350 |
Why?
|
| Treatment Outcome | 11 | 2024 | 5697 | 0.330 |
Why?
|
| Phantoms, Imaging | 2 | 2024 | 225 | 0.320 |
Why?
|
| Neointima | 2 | 2018 | 19 | 0.290 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2018 | 212 | 0.260 |
Why?
|
| Swine | 3 | 2024 | 395 | 0.240 |
Why?
|
| Surface Properties | 2 | 2024 | 281 | 0.230 |
Why?
|
| Inflammation | 2 | 2023 | 1162 | 0.230 |
Why?
|
| Random Allocation | 3 | 2020 | 201 | 0.230 |
Why?
|
| Middle Cerebral Artery | 2 | 2023 | 50 | 0.220 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 927 | 0.210 |
Why?
|
| Carotid Artery, Common | 1 | 2024 | 29 | 0.210 |
Why?
|
| Contrast Media | 2 | 2024 | 429 | 0.210 |
Why?
|
| Central Nervous System | 3 | 2024 | 197 | 0.210 |
Why?
|
| Microscopy | 2 | 2024 | 94 | 0.210 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2023 | 6 | 0.210 |
Why?
|
| Thromboembolism | 1 | 2024 | 73 | 0.210 |
Why?
|
| Drug-Eluting Stents | 1 | 2024 | 66 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2023 | 288 | 0.200 |
Why?
|
| Organometallic Compounds | 1 | 2023 | 71 | 0.200 |
Why?
|
| Wound Healing | 1 | 2024 | 192 | 0.190 |
Why?
|
| Iron | 1 | 2023 | 154 | 0.190 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 327 | 0.190 |
Why?
|
| Neurosurgical Procedures | 1 | 2023 | 101 | 0.180 |
Why?
|
| Subarachnoid Space | 1 | 2022 | 10 | 0.180 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 47 | 0.180 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 39 | 0.170 |
Why?
|
| Embolism | 1 | 2021 | 41 | 0.170 |
Why?
|
| C9orf72 Protein | 1 | 2021 | 114 | 0.170 |
Why?
|
| Phenotype | 1 | 2024 | 1222 | 0.170 |
Why?
|
| Male | 9 | 2024 | 30323 | 0.170 |
Why?
|
| Vertebral Artery | 1 | 2020 | 28 | 0.160 |
Why?
|
| Carotid Arteries | 1 | 2020 | 61 | 0.160 |
Why?
|
| Cisterna Magna | 1 | 2019 | 15 | 0.160 |
Why?
|
| Device Removal | 1 | 2020 | 65 | 0.160 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 45 | 0.160 |
Why?
|
| Cryotherapy | 1 | 2019 | 16 | 0.150 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 38 | 0.150 |
Why?
|
| Biomechanical Phenomena | 1 | 2020 | 273 | 0.150 |
Why?
|
| Hemodynamics | 1 | 2020 | 249 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2020 | 677 | 0.150 |
Why?
|
| Mutation | 3 | 2022 | 2629 | 0.150 |
Why?
|
| Neuronavigation | 1 | 2018 | 13 | 0.140 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 145 | 0.140 |
Why?
|
| Cone-Beam Computed Tomography | 2 | 2017 | 72 | 0.140 |
Why?
|
| Acute Disease | 1 | 2020 | 672 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 233 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 666 | 0.140 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 239 | 0.140 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 695 | 0.140 |
Why?
|
| Genetic Therapy | 2 | 2021 | 802 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 324 | 0.130 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2017 | 24 | 0.130 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2017 | 49 | 0.130 |
Why?
|
| Humans | 19 | 2024 | 64279 | 0.120 |
Why?
|
| Gene Expression | 1 | 2019 | 851 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2015 | 63 | 0.110 |
Why?
|
| Female | 7 | 2020 | 33382 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 2019 | 889 | 0.100 |
Why?
|
| Dependovirus | 1 | 2019 | 721 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1621 | 0.090 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 275 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2023 | 6742 | 0.090 |
Why?
|
| Carotid Artery, Internal | 2 | 2023 | 68 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 848 | 0.080 |
Why?
|
| Sheep | 2 | 2021 | 182 | 0.080 |
Why?
|
| Time Factors | 1 | 2017 | 3726 | 0.080 |
Why?
|
| Pancreatic Elastase | 2 | 2020 | 32 | 0.080 |
Why?
|
| Hyperplasia | 2 | 2018 | 89 | 0.070 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2019 | 59 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 2 | 2020 | 183 | 0.060 |
Why?
|
| Ethiodized Oil | 1 | 2024 | 7 | 0.060 |
Why?
|
| Enbucrilate | 1 | 2024 | 9 | 0.060 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.060 |
Why?
|
| Miniaturization | 1 | 2024 | 10 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 1669 | 0.050 |
Why?
|
| Mice | 3 | 2024 | 11003 | 0.050 |
Why?
|
| Philadelphia Chromosome | 1 | 2023 | 3 | 0.050 |
Why?
|
| Imatinib Mesylate | 1 | 2023 | 34 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2023 | 35 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 189 | 0.050 |
Why?
|
| Intravital Microscopy | 1 | 2022 | 12 | 0.050 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2021 | 22 | 0.050 |
Why?
|
| Computed Tomography Angiography | 1 | 2023 | 129 | 0.050 |
Why?
|
| Motor Activity | 1 | 2024 | 346 | 0.050 |
Why?
|
| Microsurgery | 1 | 2022 | 52 | 0.040 |
Why?
|
| Brain | 2 | 2019 | 1581 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 313 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 321 | 0.040 |
Why?
|
| Arteries | 1 | 2020 | 80 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 65 | 0.040 |
Why?
|
| Angiography | 1 | 2020 | 151 | 0.040 |
Why?
|
| Cadaver | 1 | 2020 | 129 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2021 | 404 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 46 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 127 | 0.040 |
Why?
|
| Lung | 1 | 2024 | 964 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 375 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 224 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 2019 | 40 | 0.040 |
Why?
|
| Cerebral Revascularization | 1 | 2019 | 30 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 260 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 173 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 240 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 188 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 155 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 429 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 81 | 0.040 |
Why?
|
| Cattle | 1 | 2019 | 316 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1297 | 0.030 |
Why?
|
| Catheterization | 1 | 2018 | 113 | 0.030 |
Why?
|
| Phosphorus | 1 | 2017 | 16 | 0.030 |
Why?
|
| Choline | 1 | 2017 | 23 | 0.030 |
Why?
|
| Angioplasty | 1 | 2017 | 51 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2018 | 124 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 788 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 934 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1176 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2018 | 222 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2015 | 234 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1551 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2482 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 1683 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2011 | 61 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 490 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1029 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5342 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 17923 | 0.010 |
Why?
|